Strides in talks to acquire all of Australian arm
16 March 2010
Anju Ghangurde
Please Login to read the full article.
16 March 2010
Anju Ghangurde
aghangurde@yahoo.com
Strides Arcolab is in discussions with its 57%-owned Australian subsidiary, Ascent Pharmahealth, to take it private.
While no formal offer has been made, Strides informed the Bombay Stock Exchange that an indicative proposal involved a cash offer of Aus$0.35 per Ascent share, which pegs the...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Strides mulls sell-off of pharma unit amid evolving strategic gameplan
- US Capitol Capsule: Will pharma get fried in the debt ceiling chicken game?
- Amgen to swallow $1.16B Micromet in one BiTE, like a cytotoxic T cell on a tumour
- What do promising prostate cancer drug results mean for Dendreon?
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
